Torii Pharmaceutical Co., Ltd. (4551.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In JPY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
592
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Goichi Matsuda | Chief Executive Officer, President & Representative Director | 0 | 1967 |
| Nobumasa Kondo | Chief Executive Officer, President & Representative Director | 0 | 1968 |
| Atsuyuki Kakee | Managing Executive Officer, Leader of Value Creation Group & GM of Business Development Department | 0 | N/A |
| Katsunobu Fujiwara | Head of Pharmaceutical Marketing & Promotion Group and Director | 0 | 1963 |
| Yukihiro Takashima | General Manager of Finance & Accounting Department | 0 | N/A |
| Noriaki Nishino | Executive Officer, Head of Pharmacovigilance & Quality Assu Grp and Quality Assurance Grp Leader | 0 | N/A |
| Shinichiro Arikawa | Senior Executive Officer and Head of Planning & Administration Group | 0 | N/A |
| Yuichiro Takeuchi | Executive Officer and Head of Pharmaceutical Marketing & Promotion Group | 0 | N/A |
| Gen Matsuo | Executive Officer & Head of Innovation Group | 0 | N/A |
| Koji Matsuda | Executive Officer & Head of Production Group | 0 | N/A |
Operating within Japan, Torii Pharmaceutical Co., Ltd. specializes in the development and commercialization of various medicinal products. Its product lineup includes Riona, an agent for treating hyperphosphatemia, and REMITCH, an oral medication addressing pruritus in patients with dialysis-related or liver conditions. The company also provides ANTEBATE, an anti-inflammatory drug prescribed for skin ailments like atopic and contact dermatitis. Additionally, their portfolio features allergen immunotherapy tablets, specifically CEDARCURE and MITICURE, along with CORECTIM, a topical janus kinase (JAK) inhibitor. Torii Pharmaceutical primarily promotes these offerings to healthcare professionals through its dedicated team of medical representatives. Founded in 1872 as Torii Shoten K.K., the company officially became Torii Pharmaceutical Co., Ltd. in May 1949. It is headquartered in Tokyo, Japan, and operates as a subsidiary of Japan Tobacco Inc.